Literature DB >> 25191973

Detection of immunoglobulin IgA and IgG against human papilloma virus.

Ana Katherine Gonçalves1, Paula Renata Lima Machado, Luanda Canário de Souza, Ana Paula Ferreira Costa, Fabrícia Gimenes, Marcia Lopes Consolaro, Janaina Oliveira Crispim, Jose Eleutério, Paulo César Giraldo.   

Abstract

The interest in human papilloma virus (HPV) seropositivity has increased considerably since HPV vaccines have become available worldwide. The aim of this study was to assess the performance of enzyme-linked immunosorbent assay (ELISA) in analyzing serum samples provided from women with and without genital DNA-HPV infection confirmed by polymerase chain reaction (PCR), for detection of specific antibodies of the isotypes IgG and IgA recognizing HPV-16 and -18, as well as virus-like particles (VLPs). From August to December 2013, 50 sexually active female patients between 18 and 35 years of age from the outpatient clinic at the university hospital were enrolled. In order to test them, positive controls were obtained from patients with HPV-induced lesions and who were DNA-HPV positive confirmed by PCR. A specific assay was used to identify antibodies to HPV VLPs by ELISA. The samples were divided into HPV positive and negative, and an ELISA detecting IgA and IgG anti-HPV-VLP was carried out. The effectiveness of ELISA and the kappa (k) index was obtained from the values entered in the receiver operating characteristic (ROC) curves for IgG and IgA. IgG-VLP-HPV-16 showed a good correlation between ELISA and PCR (k=0.75), and IgG-VLP-HPV-18 showed a very good correlation between ELISA and PCR (k=0.84). While the IgA antibody correlation was also positive, although weaker, IgA-VLP-HPV-16 was moderate (k=0.45) and IgA-VLP-HPV-18 good (k=0.66). The efficacy of the assay concerning IgG was: sensitivity, specificity, and accuracy were 82.3%, 92%, and 88% to IgG-VLP-HPV-16, and 100%, 92%, and 94% to IgG-VLP-HPV-18. The assay concerning IgA was: sensitivity, specificity, and accuracy were 64.7%, 80%, and 73.8% to IgA-VLP-HPV-16, and 100%, 80%, and 84.8% to IgA-VLP-HPV-18. IgG and IgA antibodies against HPV-16 and -18 can be detected in unvaccinated individuals by using the VLP that serve as the basis for bivalent HPV vaccine. The values for ELISA assays and the values found for IgG correlate good/very good with HPV-16/18 detected by PCR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25191973     DOI: 10.1089/vim.2014.0033

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  5 in total

1.  Increased Serum Antibody Titer against HPV-16 Antigen in Patients with Behçet's Disease.

Authors:  Kyu Yeun Kim; Do Young Kim; Jimyung Seo; Yuri Ahn; Dong Soo Kim
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

2.  In reply: the evaluation of IgG titers' stability from blood samples is necessary.

Authors:  Yung Taek Ouh; Jae Kwan Lee
Journal:  J Gynecol Oncol       Date:  2020-03       Impact factor: 4.401

3.  Differential Antibody Response against Conformational and Linear Epitopes of the L1 Proteins from Human Papillomavirus Types 16/18 Is Observed in Vaccinated Women or with Uterine Cervical Lesions.

Authors:  Adolfo Pedroza-Saavedra; Angelica Nallelhy Rodriguez-Ocampo; Azucena Salazar-Piña; Aislinn Citlali Perez-Morales; Lilia Chihu-Amparan; Minerva Maldonado-Gama; Aurelio Cruz-Valdez; Fernando Esquivel-Guadarrama; Lourdes Gutierrez-Xicotencatl
Journal:  Vaccines (Basel)       Date:  2021-05-02

4.  Immune Response to Human Papillomavirus One Year after Prophylactic Vaccination with AS04-Adjuvanted HPV-16/18 Vaccine: HPV-Specific IgG and IgA Antibodies in the Circulation and the Cervix

Authors:  Ana Paula Ferreira Costa; Ana Katherine Gonçalves; Paula Renata Lima Machado; Luanda B. F. C. de Souza; Ayane Sarmento; Ricardo Ney Oliveira Cobucci; Paulo César Giraldo; Steven S Witkin
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

5.  Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes.

Authors:  Ana Paula Costa; Paulo César Giraldo; Ricardo Ney Cobucci; Márcia Lopes Consolaro; Raquel Pantarotto Souza; Luanda Barbara Canário; Paula Renata Machado; Rand Randall Martins; Pedro Vieira Baptista; José Eleutério Jr; Ana Katherine Gonçalves
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.